TrialThe Journal of dermatology2025

An Open-Label, Multicenter, Phase II Study of Bexarotene in Patients with Adult T-Cell Leukemia/Lymphoma.

Kentaro Yonekura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.